279 related articles for article (PubMed ID: 28804704)
1. Hypoxia in cervical cancer: from biology to imaging.
Lyng H; Malinen E
Clin Transl Imaging; 2017; 5(4):373-388. PubMed ID: 28804704
[TBL] [Abstract][Full Text] [Related]
2. The clinical utility of imaging methods used to measure hypoxia in cervical cancer.
Waller J; Onderdonk B; Flood A; Swartz H; Shah J; Shah A; Aydogan B; Halpern H; Hasan Y
Br J Radiol; 2020 Jul; 93(1111):20190640. PubMed ID: 32286849
[TBL] [Abstract][Full Text] [Related]
3. Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.
Georg P; Andrzejewski P; Baltzer P; Daniel M; Wadsak W; Mitterhauser M; Sturdza A; Majercakova K; Karanikas G; Pötter R; Hacker M; Helbich T; Georg D; Pinker K
Mol Imaging Biol; 2018 Feb; 20(1):160-169. PubMed ID: 28540524
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging (PET) of brain tumors.
Basu S; Alavi A
Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
Pinker K; Andrzejewski P; Baltzer P; Polanec SH; Sturdza A; Georg D; Helbich TH; Karanikas G; Grimm C; Polterauer S; Poetter R; Wadsak W; Mitterhauser M; Georg P
PLoS One; 2016; 11(5):e0155333. PubMed ID: 27167829
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Role of 3T multiparametric-MRI with BOLD hypoxia imaging for diagnosis and post therapy response evaluation of postoperative recurrent cervical cancers.
Mahajan A; Engineer R; Chopra S; Mahanshetty U; Juvekar SL; Shrivastava SK; Desekar N; Thakur MH
Eur J Radiol Open; 2016; 3():22-30. PubMed ID: 27069975
[TBL] [Abstract][Full Text] [Related]
9. Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.
Schuetz M; Schmid MP; Pötter R; Kommata S; Georg D; Lukic D; Dudczak R; Kletter K; Dimopoulos J; Karanikas G; Bachtiary B
Acta Oncol; 2010 Oct; 49(7):941-7. PubMed ID: 20831481
[TBL] [Abstract][Full Text] [Related]
10. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer.
Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R
Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966
[TBL] [Abstract][Full Text] [Related]
11. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
Fischerová D; Cibula D
Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
[TBL] [Abstract][Full Text] [Related]
12. Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT.
Even AJG; Reymen B; La Fontaine MD; Das M; Jochems A; Mottaghy FM; Belderbos JSA; De Ruysscher D; Lambin P; van Elmpt W
Acta Oncol; 2017 Nov; 56(11):1591-1596. PubMed ID: 28840770
[TBL] [Abstract][Full Text] [Related]
13. Impact of hybrid PET/MR technology on multiparametric imaging and treatment response assessment of cervix cancer.
Daniel M; Andrzejewski P; Sturdza A; Majercakova K; Baltzer P; Pinker K; Wadsak W; Mitterhauser M; Pötter R; Georg P; Helbich T; Georg D
Radiother Oncol; 2017 Dec; 125(3):420-425. PubMed ID: 29153465
[TBL] [Abstract][Full Text] [Related]
14. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.
Chao KS; Bosch WR; Mutic S; Lewis JS; Dehdashti F; Mintun MA; Dempsey JF; Perez CA; Purdy JA; Welch MJ
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1171-82. PubMed ID: 11240261
[TBL] [Abstract][Full Text] [Related]
15. How to use PET/CT in the evaluation of response to radiotherapy.
Decazes P; Thureau S; Dubray B; Vera P
Q J Nucl Med Mol Imaging; 2018 Jun; 62(2):152-164. PubMed ID: 29186937
[TBL] [Abstract][Full Text] [Related]
16. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study.
Mongula JE; Bakers FCH; Vöö S; Lutgens L; van Gorp T; Kruitwagen RFPM; Slangen BFM
EJNMMI Res; 2018 Jan; 8(1):1. PubMed ID: 29292485
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.
Rumley CN; Lee MT; Holloway L; Rai R; Min M; Forstner D; Fowler A; Liney G
BMC Cancer; 2017 Jul; 17(1):475. PubMed ID: 28693449
[TBL] [Abstract][Full Text] [Related]
19. Dose prescription and treatment planning based on FMISO-PET hypoxia.
Toma-Dasu I; Uhrdin J; Antonovic L; Dasu A; Nuyts S; Dirix P; Haustermans K; Brahme A
Acta Oncol; 2012 Feb; 51(2):222-30. PubMed ID: 21871003
[TBL] [Abstract][Full Text] [Related]
20. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]